Achieve Life Sciences, Inc.
ACHV
$5.99
$0.407.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 31.88M | 25.92M | 21.40M | 18.87M | 16.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.88M | 52.34M | 50.11M | 45.98M | 39.07M |
| Operating Income | -54.88M | -52.34M | -50.11M | -45.98M | -39.07M |
| Income Before Tax | -54.65M | -52.35M | -50.42M | -46.16M | -39.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -54.65 | -52.35 | -50.42 | -46.16 | -39.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.65M | -52.35M | -50.42M | -46.16M | -39.83M |
| EBIT | -54.88M | -52.34M | -50.11M | -45.98M | -39.07M |
| EBITDA | -54.65M | -52.11M | -49.88M | -45.75M | -38.84M |
| EPS Basic | -1.29 | -1.38 | -1.46 | -1.34 | -1.23 |
| Normalized Basic EPS | -0.80 | -0.85 | -0.89 | -0.82 | -0.75 |
| EPS Diluted | -1.29 | -1.38 | -1.46 | -1.34 | -1.23 |
| Normalized Diluted EPS | -0.80 | -0.85 | -0.89 | -0.82 | -0.75 |
| Average Basic Shares Outstanding | 173.66M | 154.90M | 138.24M | 137.87M | 128.23M |
| Average Diluted Shares Outstanding | 173.66M | 154.90M | 138.24M | 137.87M | 128.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |